CQDM. We grow. Welcome to Julia Serafino, our new Marketing and Communications Coordinator at CQDM! With a master’s degree in marketing and communications, Julia brings over 8 years of experience in the healthcare marketing sector. Before joining our team, she successfully worked for COLOPLAST, a medical devices laboratory, where she developed extensive skills in crafting…
CQDM, HEMARINA Canada and Mitacs fund oncology research evaluating the therapeutic potential of a marine oxygen carrier Montreal, April 18, 2024 – CQDM is proud to announce the funding of a collaborative research project aimed at evaluating the therapeutic potential of a universal oxygen carrier from a marine organism in various oncology applications. This project,…
CQDM, RejuvenRx and the fond Partenariat de l’Université de Montréal fund a research project promoting cellular rejuvenation. Montreal, April 9, 2024 – CQDM is proud to announce the funding of a collaborative research project led by Guy Sauvageau, Anne Marinier and RejuvenRx. Funding for this collaborative research project, for a total amount of $3,697,199, is…
CQDM, Vega BioImagerie and Pfizer Canada Fund the Development of a New Diagnostic Technique for Targeted Treatment of Breast Cancer: Montreal, March 21, 2024 – CQDM is proud to announce the funding of a collaborative research project led by Michel Meunier, professor in the Department of Engineering Physics at Polytechnique Montréal, in partnership with Vega…
Principal Investigator: Nicolas Pilon / Université du Québec à Montréal – UQAM Co-Investigators : Lekha Sleno / Université du Québec à Montréal – UQAM Project of $1 500 000 over 3 years Supported by CQDM through : Ministère de l’Économie, de l’Innovation et de l’Énergie du Québec (MEIE) And by co-funding partners: Neurenati The project in details : Challenge: …
Principal Investigator: François-Xavier Lacasse / UdeM Co-Investigators: John Sampalis, Ramy Saleh / RI-MUHC Gabi Hanna / Saydi Biotech Project of $3,342,000 over 3 years Supported by CQDM through: Ministère de l’Économie, de l’Innovation et de l’Énergie du Québec (MEIE) And by co-funding partners: Saydi Biotech The project in details: Challenge: All human cells have an…
Principal Investigator: David Guay / Feldan Therapeutics Co-Investigators: Frédéric Couture / TransBio Tech Project of $1,363,590 over 2 years Supported by CQDM through: Ministère de l’Économie, de l’Innovation et de l’Énergie du Québec (MEIE) And by co-funding partners: Feldan Therapeutics, Amgen Canada The project in details: Challenge: Lung diseases are one of the leading causes…
Principal Investigator: Nathalie Johnson / Jewish General Hospital Co-Investigators: N/A Project of $583,800 over 3 years Supported by CQDM through: Ministère de l’Économie, de l’Innovation et de l’Énergie du Québec (MEIE) And by co-funding partners: Hoffman-La Roche, JGH Foundation The project in details: Challenge: Diffuse large B cells lymphoma (DLBCL) is the most common lymphoma…
CQDM celebrates its 15th anniversary with encouraging messages from its partners and founders: -Pierre Fitzgibbon, Quebec Minister of Economy, Innovation and Energy (MEIE) -Diane Gosselin, CEO of CQDM -Rémi Quirion, Chief Scientist of Quebec -Max Fehlmann, Founder CQDM -Jennifer Chan, MERCK Canada -Vratislav Hadrava, Pfizer Canada A big thank you for your contributions and for…
ABOUT CQDMCQDM is a biopharmaceutical research consortium whose mission is to fund the development of innovative tools and technologies that accelerate the development of safe and effective drugs. We bring together world-leading pharmaceutical organizations, several Canadian biotech companies, the best researchers from the public and private sectors, as well as the Canadian and Québec governments.…